{"pmid":32325252,"title":"COVID-19 pathophysiology: A review.","text":["COVID-19 pathophysiology: A review.","In December 2019, a novel coronavirus, now named as SARS-CoV-2, caused a series of acute atypical respiratory diseases in Wuhan, Hubei Province, China. The disease caused by this virus was termed COVID-19. The virus is transmittable between humans and has caused pandemic worldwide. The number of death tolls continues to rise and a large number of countries have been forced to do social distancing and lockdown. Lack of targeted therapy continues to be a problem. Epidemiological studies showed that elder patients were more susceptible to severe diseases, while children tend to have milder symptoms. Here we reviewed the current knowledge about this disease and considered the potential explanation of the different symptomatology between children and adults.","Clin Immunol","Yuki, Koichi","Fujiogi, Miho","Koutsogiannaki, Sophia","32325252"],"abstract":["In December 2019, a novel coronavirus, now named as SARS-CoV-2, caused a series of acute atypical respiratory diseases in Wuhan, Hubei Province, China. The disease caused by this virus was termed COVID-19. The virus is transmittable between humans and has caused pandemic worldwide. The number of death tolls continues to rise and a large number of countries have been forced to do social distancing and lockdown. Lack of targeted therapy continues to be a problem. Epidemiological studies showed that elder patients were more susceptible to severe diseases, while children tend to have milder symptoms. Here we reviewed the current knowledge about this disease and considered the potential explanation of the different symptomatology between children and adults."],"journal":"Clin Immunol","authors":["Yuki, Koichi","Fujiogi, Miho","Koutsogiannaki, Sophia"],"date":"2020-04-24T11:00:00Z","year":2020,"_id":"32325252","week":"202017|Apr 20 - Apr 26","doi":"10.1016/j.clim.2020.108427","source":"PubMed","topics":["Mechanism"],"weight":1,"locations":["Wuhan","Hubei","China"],"countries":["China"],"countries_codes":["CHN|China"],"_version_":1664895932667265024,"score":8.518259,"similar":[{"pmid":32112977,"pmcid":"PMC7105032","title":"World Health Organization declares global emergency: A review of the 2019 novel coronavirus (COVID-19).","text":["World Health Organization declares global emergency: A review of the 2019 novel coronavirus (COVID-19).","An unprecedented outbreak of pneumonia of unknown aetiology in Wuhan City, Hubei province in China emerged in December 2019. A novel coronavirus was identified as the causative agent and was subsequently termed COVID-19 by the World Health Organization (WHO). Considered a relative of severe acute respiratory syndrome (SARS) and Middle East respiratory syndrome (MERS), COVID-19 is caused by a betacoronavirus named SARS-CoV-2 that affects the lower respiratory tract and manifests as pneumonia in humans. Despite rigorous global containment and quarantine efforts, the incidence of COVID-19 continues to rise, with 90,870 laboratory-confirmed cases and over 3,000 deaths worldwide. In response to this global outbreak, we summarise the current state of knowledge surrounding COVID-19.","Int J Surg","Sohrabi, Catrin","Alsafi, Zaid","O'Neill, Niamh","Khan, Mehdi","Kerwan, Ahmed","Al-Jabir, Ahmed","Iosifidis, Christos","Agha, Riaz","32112977"],"abstract":["An unprecedented outbreak of pneumonia of unknown aetiology in Wuhan City, Hubei province in China emerged in December 2019. A novel coronavirus was identified as the causative agent and was subsequently termed COVID-19 by the World Health Organization (WHO). Considered a relative of severe acute respiratory syndrome (SARS) and Middle East respiratory syndrome (MERS), COVID-19 is caused by a betacoronavirus named SARS-CoV-2 that affects the lower respiratory tract and manifests as pneumonia in humans. Despite rigorous global containment and quarantine efforts, the incidence of COVID-19 continues to rise, with 90,870 laboratory-confirmed cases and over 3,000 deaths worldwide. In response to this global outbreak, we summarise the current state of knowledge surrounding COVID-19."],"journal":"Int J Surg","authors":["Sohrabi, Catrin","Alsafi, Zaid","O'Neill, Niamh","Khan, Mehdi","Kerwan, Ahmed","Al-Jabir, Ahmed","Iosifidis, Christos","Agha, Riaz"],"date":"2020-03-01T11:00:00Z","year":2020,"_id":"32112977","week":"20209|Feb 24 - Mar 01","doi":"10.1016/j.ijsu.2020.02.034","keywords":["covid-19","global health emergency","novel coronavirus","viral transmission","wuhan"],"link_erratum_in":"32305321","link_comment_in":"32169574","source":"PubMed","topics":["Transmission","Mechanism","Diagnosis","Prevention"],"weight":1,"locations":["Wuhan","Hubei","China"],"countries":["China"],"countries_codes":["CHN|China"],"_version_":1664640875073896448,"score":207.79176},{"pmid":32202343,"title":"Systematic review of COVID-19 in children shows milder cases and a better prognosis than adults.","text":["Systematic review of COVID-19 in children shows milder cases and a better prognosis than adults.","AIM: The coronavirus disease 2019 (COVID-19) pandemic has affected hundreds of thousands of people. Data on symptoms and prognosis in children are rare. METHODS: A systematic literature review was carried out to identify papers on COVID-19, which is caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), using the MEDLINE and Embase databases between January 1 and March 18, 2020. RESULTS: The search identified 45 relevant scientific papers and letters. The review showed that children have so far accounted for 1%-5% of diagnosed COVID-19 cases, they often have milder disease than adults and deaths have been extremely rare. Diagnostic findings have been similar to adults, with fever and respiratory symptoms being prevalent, but fewer children seem to have developed severe pneumonia. Elevated inflammatory markers were less common in children, and lymphocytopenia seemed rare. Newborn infants have developed symptomatic COVID-19, but evidence of vertical intrauterine transmission was scarce. Suggested treatment included providing oxygen, inhalations, nutritional support and maintaining fluids and electrolyte balances. CONCLUSIONS: The coronavirus disease 2019 has occurred in children, but they seemed to have a milder disease course and better prognosis than adults. Deaths were extremely rare.","Acta Paediatr","Ludvigsson, Jonas F","32202343"],"abstract":["AIM: The coronavirus disease 2019 (COVID-19) pandemic has affected hundreds of thousands of people. Data on symptoms and prognosis in children are rare. METHODS: A systematic literature review was carried out to identify papers on COVID-19, which is caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), using the MEDLINE and Embase databases between January 1 and March 18, 2020. RESULTS: The search identified 45 relevant scientific papers and letters. The review showed that children have so far accounted for 1%-5% of diagnosed COVID-19 cases, they often have milder disease than adults and deaths have been extremely rare. Diagnostic findings have been similar to adults, with fever and respiratory symptoms being prevalent, but fewer children seem to have developed severe pneumonia. Elevated inflammatory markers were less common in children, and lymphocytopenia seemed rare. Newborn infants have developed symptomatic COVID-19, but evidence of vertical intrauterine transmission was scarce. Suggested treatment included providing oxygen, inhalations, nutritional support and maintaining fluids and electrolyte balances. CONCLUSIONS: The coronavirus disease 2019 has occurred in children, but they seemed to have a milder disease course and better prognosis than adults. Deaths were extremely rare."],"journal":"Acta Paediatr","authors":["Ludvigsson, Jonas F"],"date":"2020-03-24T11:00:00Z","year":2020,"_id":"32202343","week":"202013|Mar 23 - Mar 29","doi":"10.1111/apa.15270","keywords":["2019-ncov","covid-19","sars-cov2","children","coronavirus","newborn"],"source":"PubMed","topics":["Mechanism","Diagnosis","Treatment"],"weight":1,"_version_":1664639760388325376,"score":181.84341},{"pmid":32234465,"pmcid":"PMC7118423","title":"Recent progress in understanding 2019 novel coronavirus (SARS-CoV-2) associated with human respiratory disease: detection, mechanisms and treatment.","text":["Recent progress in understanding 2019 novel coronavirus (SARS-CoV-2) associated with human respiratory disease: detection, mechanisms and treatment.","Viral respiratory diseases such as severe acute respiratory syndrome (SARS) and Middle East respiratory syndrome (MERS) always pose a severe threat to people. First identified in late December 2019, a novel coronavirus (2019-nCoV; SARS-CoV-2) has affected many provinces in China and multiple countries worldwide. The viral outbreak has aroused panic and a public-health emergency around the world, and the number of infections continues to rise. However, the causes and consequences of the pneumonia remain unknown. To effectively implement epidemic prevention, early identification and diagnosis are critical to disease control. Here we scrutinise a series of available studies by global scientists on the clinical manifestations, detection methods and treatment options for the disease caused by SARS-CoV-2, named coronavirus disease 2019 (COVID-19), and also propose potential strategies for preventing the infection.","Int J Antimicrob Agents","Kang, Shuntong","Peng, Wenyao","Zhu, Yuhao","Lu, Shiyao","Zhou, Min","Lin, Wei","Wu, Wenfang","Huang, Shu","Jiang, Liping","Luo, Xuan","Deng, Meichun","32234465"],"abstract":["Viral respiratory diseases such as severe acute respiratory syndrome (SARS) and Middle East respiratory syndrome (MERS) always pose a severe threat to people. First identified in late December 2019, a novel coronavirus (2019-nCoV; SARS-CoV-2) has affected many provinces in China and multiple countries worldwide. The viral outbreak has aroused panic and a public-health emergency around the world, and the number of infections continues to rise. However, the causes and consequences of the pneumonia remain unknown. To effectively implement epidemic prevention, early identification and diagnosis are critical to disease control. Here we scrutinise a series of available studies by global scientists on the clinical manifestations, detection methods and treatment options for the disease caused by SARS-CoV-2, named coronavirus disease 2019 (COVID-19), and also propose potential strategies for preventing the infection."],"journal":"Int J Antimicrob Agents","authors":["Kang, Shuntong","Peng, Wenyao","Zhu, Yuhao","Lu, Shiyao","Zhou, Min","Lin, Wei","Wu, Wenfang","Huang, Shu","Jiang, Liping","Luo, Xuan","Deng, Meichun"],"date":"2020-04-03T11:00:00Z","year":2020,"_id":"32234465","week":"202014|Mar 30 - Apr 05","doi":"10.1016/j.ijantimicag.2020.105950","keywords":["2019 novel coronavirus","2019-ncov","detection","mechanism","sars-cov-2","treatment"],"source":"PubMed","topics":["Diagnosis","Mechanism","Treatment"],"weight":1,"locations":["China"],"countries":["China"],"countries_codes":["CHN|China"],"_version_":1664638354129420288,"score":177.9273},{"pmid":32243729,"title":"The isolation period should be longer: Lesson from a child infected with SARS-CoV-2 in Chongqing, China.","text":["The isolation period should be longer: Lesson from a child infected with SARS-CoV-2 in Chongqing, China.","In December 2019, COVID-19 caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) outbroke in Wuhan, the capital city of Hubei province, China. The disease rapidly spread to other areas in China due to a huge population movement during the New Year Festival. Here, a 7-year-old child with SARS-CoV-2 infection in Chongqing, outside of Wuhan, Hubei province, was reported. This case suggested that children infected with SARS-CoV-2 are more likely to present milder manifestations than adults. The continuous positive real-time reverse transcription-polymerase chain reaction assay for SARS-CoV-2 in the child's throat swab sample indicated the isolation period for suspected child cases should be longer than 14 days.","Pediatr Pulmonol","Lin, Jilei","Duan, Jun","Tan, Tingdan","Fu, Zhou","Dai, Jihong","32243729"],"abstract":["In December 2019, COVID-19 caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) outbroke in Wuhan, the capital city of Hubei province, China. The disease rapidly spread to other areas in China due to a huge population movement during the New Year Festival. Here, a 7-year-old child with SARS-CoV-2 infection in Chongqing, outside of Wuhan, Hubei province, was reported. This case suggested that children infected with SARS-CoV-2 are more likely to present milder manifestations than adults. The continuous positive real-time reverse transcription-polymerase chain reaction assay for SARS-CoV-2 in the child's throat swab sample indicated the isolation period for suspected child cases should be longer than 14 days."],"journal":"Pediatr Pulmonol","authors":["Lin, Jilei","Duan, Jun","Tan, Tingdan","Fu, Zhou","Dai, Jihong"],"date":"2020-04-04T11:00:00Z","year":2020,"_id":"32243729","week":"202014|Mar 30 - Apr 05","doi":"10.1002/ppul.24763","source":"PubMed","topics":["Case Report"],"weight":1,"locations":["Wuhan","Hubei","China","China","Chongqing","Wuhan","Hubei","Chongqing","China"],"countries":["China"],"countries_codes":["CHN|China"],"_version_":1664638249329491970,"score":173.21297},{"pmid":32234466,"pmcid":"PMC7139247","title":"Coronavirus disease 2019 (COVID-19): current status and future perspectives.","text":["Coronavirus disease 2019 (COVID-19): current status and future perspectives.","Coronavirus disease 2019 (COVID-19) originated in the city of Wuhan, Hubei Province, Central China, and has spread quickly to 72 countries to date. COVID-19 is caused by a novel coronavirus, named severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) [previously provisionally known as 2019 novel coronavirus (2019-nCoV)]. At present, the newly identified SARS-CoV-2 has caused a large number of deaths with tens of thousands of confirmed cases worldwide, posing a serious threat to public health. However, there are no clinically approved vaccines or specific therapeutic drugs available for COVID-19. Intensive research on the newly emerged SARS-CoV-2 is urgently needed to elucidate the pathogenic mechanisms and epidemiological characteristics and to identify potential drug targets, which will contribute to the development of effective prevention and treatment strategies. Hence, this review will focus on recent progress regarding the structure of SARS-CoV-2 and the characteristics of COVID-19, such as the aetiology, pathogenesis and epidemiological characteristics.","Int J Antimicrob Agents","Li, Heng","Liu, Shang-Ming","Yu, Xiao-Hua","Tang, Shi-Lin","Tang, Chao-Ke","32234466"],"abstract":["Coronavirus disease 2019 (COVID-19) originated in the city of Wuhan, Hubei Province, Central China, and has spread quickly to 72 countries to date. COVID-19 is caused by a novel coronavirus, named severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) [previously provisionally known as 2019 novel coronavirus (2019-nCoV)]. At present, the newly identified SARS-CoV-2 has caused a large number of deaths with tens of thousands of confirmed cases worldwide, posing a serious threat to public health. However, there are no clinically approved vaccines or specific therapeutic drugs available for COVID-19. Intensive research on the newly emerged SARS-CoV-2 is urgently needed to elucidate the pathogenic mechanisms and epidemiological characteristics and to identify potential drug targets, which will contribute to the development of effective prevention and treatment strategies. Hence, this review will focus on recent progress regarding the structure of SARS-CoV-2 and the characteristics of COVID-19, such as the aetiology, pathogenesis and epidemiological characteristics."],"journal":"Int J Antimicrob Agents","authors":["Li, Heng","Liu, Shang-Ming","Yu, Xiao-Hua","Tang, Shi-Lin","Tang, Chao-Ke"],"date":"2020-04-03T11:00:00Z","year":2020,"_id":"32234466","week":"202014|Mar 30 - Apr 05","doi":"10.1016/j.ijantimicag.2020.105951","keywords":["2019-ncov","covid-19","coronavirus","pneumonia","sars-cov-2"],"source":"PubMed","topics":["Diagnosis","Mechanism","Treatment"],"weight":1,"locations":["Wuhan","Hubei"],"countries":["China"],"countries_codes":["CHN|China"],"_version_":1664638354080137216,"score":169.10167}]}